Venkata Jayanti

ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease

Hing L. Sham, Dale J. Kempf, Akhteruzammen Molla et al. · Antimicrobial Agents and Chemotherapy · 1998 · 468 citations · Full text

Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction

Gondi Kumar, J.C. Dykstra, Ellen Roberts et al. · Drug Metabolism and Disposition · 1999 · 166 citations

Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans

Gondi Kumar, Venkata Jayanti, Marianne K. Johnson et al. · Pharmaceutical Research · 2004 · 105 citations

Medicine, Human Retrovirus, Antiviral Drug Development +7

In Vitro Metabolism of the HIV-1 Protease Inhibitor ABT-378: Species Comparison and Metabolite Identification

Gondi Kumar, Venkata Jayanti, Ronald Lee et al. · Drug Metabolism and Disposition · 1999 · 64 citations

Structure–activity studies for a novel series of tricyclic dihydropyridopyrazolones and dihydropyridoisoxazolones as KATP channel openers

Irene Drizin, Robert J. Altenbach, Steven A. Buckner et al. · Bioorganic & Medicinal Chemistry · 2004 · 38 citations

Structure–activity Studies, Novel Series, Heterocyclic +5